CADL
Price
$6.04
Change
+$0.49 (+8.83%)
Updated
Jun 6 closing price
Capitalization
302.62M
88 days until earnings call
CCCC
Price
$1.73
Change
+$0.26 (+17.69%)
Updated
Jun 6 closing price
Capitalization
122.84M
60 days until earnings call
Interact to see
Advertisement

CADL vs CCCC

Header iconCADL vs CCCC Comparison
Open Charts CADL vs CCCCBanner chart's image
Candel Therapeutics
Price$6.04
Change+$0.49 (+8.83%)
Volume$1.14M
Capitalization302.62M
C4 Therapeutics
Price$1.73
Change+$0.26 (+17.69%)
Volume$1.28M
Capitalization122.84M
CADL vs CCCC Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. CCCC commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Buy and CCCC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CADL: $6.04 vs. CCCC: $1.73)
Brand notoriety: CADL and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 124% vs. CCCC: 115%
Market capitalization -- CADL: $302.62M vs. CCCC: $122.84M
CADL [@Biotechnology] is valued at $302.62M. CCCC’s [@Biotechnology] market capitalization is $122.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 5 TA indicator(s) are bullish while CCCC’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 5 bullish, 4 bearish.
  • CCCC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than CCCC.

Price Growth

CADL (@Biotechnology) experienced а +10.83% price change this week, while CCCC (@Biotechnology) price change was +38.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

CCCC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($303M) has a higher market cap than CCCC($123M). CADL YTD gains are higher at: -30.415 vs. CCCC (-51.944). CADL has higher annual earnings (EBITDA): -48.83M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. CADL (16.6M). CADL has less debt than CCCC: CADL (16M) vs CCCC (64.4M). CCCC has higher revenues than CADL: CCCC (39.8M) vs CADL (0).
CADLCCCCCADL / CCCC
Capitalization303M123M246%
EBITDA-48.83M-102.74M48%
Gain YTD-30.415-51.94459%
P/E RatioN/AN/A-
Revenue039.8M-
Total Cash16.6M215M8%
Total Debt16M64.4M25%
TECHNICAL ANALYSIS
Technical Analysis
CADLCCCC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAASX28.57N/A
N/A
Fidelity Advisor Asset Manager 70% A
GTSDX8.42N/A
N/A
Invesco Small Cap Growth C
INFRX9.06N/A
N/A
Tortoise Energy Infrastructure and Inc A
DALCX26.36N/A
N/A
Dean Mid Cap Value
CSQCX9.51N/A
N/A
Calvert Global Small-Cap Equity C

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+8.83%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
42%
Loosely correlated
-1.34%
INO - CADL
36%
Loosely correlated
+7.08%
CCCC - CADL
34%
Loosely correlated
+17.69%
MDGL - CADL
33%
Poorly correlated
+1.51%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+17.69%
KYMR - CCCC
57%
Loosely correlated
-0.08%
FATE - CCCC
55%
Loosely correlated
+19.40%
BEAM - CCCC
55%
Loosely correlated
+9.26%
CRBU - CCCC
54%
Loosely correlated
+15.60%
PRME - CCCC
53%
Loosely correlated
+24.26%
More